周期性偏头痛表型与疾病进展的关联:一项为期1年的时间序列分析
本研究前瞻性收集142例偏头痛患者每月头痛频率的电子日记数据,用快速傅里叶变换分解时间序列定义周期性表型(每年超过2个周期),并以12个月后头痛频率变化率(HCR-M12)为因变量分析其与临床演变的关联。结果发现45.1%患者呈周期性表型,周期性表型(β=158.33,p=0.005)和使用预防性治疗(β=74.1,p=0.034)与HCR-M12显著相关;发作性偏头痛伴周期性表型且未充分预防治疗者与进展显著相关。
要点
- 142例偏头痛患者中45.1%呈周期性表型,即每年超过2个周期。
- 周期性表型与1年后头痛频率变化率显著相关(β=158.33,p=0.005)。
- 发作性偏头痛伴周期性表型且未充分预防治疗者与进展显著相关。
核心结论
- 每月头痛频率数据可用正弦模型拟合,周期性表型对临床演变有影响,并与1年后偏头痛进展显著相关。
- 发作性偏头痛伴周期性表型的患者头痛频率倾向于随时间增加。
- 预防性治疗似乎在调节这种周期性行为中起基础性作用,尤其在低频率发作性偏头痛患者中。
研究设计与样本
- 前瞻性收集每月头痛频率的电子日记数据,共纳入142例偏头痛患者(85.2%女性,平均年龄48.0±9.7岁),50.0%符合国际头痛疾病分类第三版慢性偏头痛标准。
- 以12个月后头痛频率变化率(HCR-M12)为因变量,通过快速傅里叶变换将每月头痛时间序列分解为正弦和,以最高功率频率定义患者1年内的周期性表型(每年周期数,c/y),周期性表型定义为每年超过2个周期。
- 使用广义线性模型研究周期性表型与HCR-M12的关联。
主要发现
- 1年后50.7%(72/142)患者改变了初始诊断,发作性偏头痛患者中14.1%(10/71)观察到进展(频率恶化)。
- 应用快速傅里叶变换后,45.1%(64/142)患者符合周期性表型。
- 广义线性模型中与HCR-M12显著相关的主效应为使用预防性治疗(β[SE]:74.1[34.6],p=0.034)和周期性表型(β[SE]:158.33[55.1],p=0.005)。
- 事后分析发现,发作性偏头痛伴周期性表型且未充分预防治疗的患者与进展显著相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Longitudinal studies assessing cyclic fluctuations of migraine attacks using time series analysis are scarce. Here, we analyze headache frequency fluctuations over a year in a cohort of patients with migraine, and we then evaluate how this behavior has an effect on clinical evolution. METHODS: Monthly headache frequency was prospectively collected using an electronic diary. Prognosis after 1 year was calculated as the headache frequency change rate after 12 months (HCR-M12) as a dependent variable. Monthly headache time series was decomposed into all the possible sum of sinusoids through a fast Fourier transform (FFT) algorithm, and the frequencies with the highest power were used to define the patient's cyclic phenotype during 1 year (patient's number of cycles per year, c/y). Patients with a cyclic phenotype were those with >2 c/y. Finally, we studied how this cyclic phenotype was associated with HCR-M12 using generalized linear models (GLMs). RESULTS: A total of 142 patients were included (85.2% female; mean age 48.0 ± 9.7 years), 50.0% fulfilled the International Classification of Headache Disorders, third edition, criteria for chronic migraine (CM). After 1 year, a 50.7% (72/142) of patients changed their initial diagnosis, and progression (frequency worsening) was observed in 14.1% (10/71) of patients with episodic migraine (EM). After applying an FFT, 45.1% (64/142) of patients fitted into a cyclic phenotype. In GLM, statistically significant main effects associated with HCR-M12 were the use of preventive therapy (β [SE]: 74.1 [34.6]; p = 0.034) and cyclic phenotype (β [SE]: 158.33 [55.1]; p = 0.005). A post hoc analysis found that patients with EM with cyclic phenotype without adequate preventive therapy were statistically significantly associated with progression. DISCUSSION: Monthly headache frequency data can be fitted by sinusoidal models. Having a cyclic phenotype has an effect on clinical evolution and has been statistically significantly associated with migraine progression after 1 year. Particularly, patients with EM with cyclic phenotype tend to increase their headache frequency over time. Preventive treatment seems to play a fundamental role in modulating this cyclic behavior, especially in patients with low-frequency EM.
引用
- Gallardo VJ, Alpuente A, Pozo-Rosich P, et al. Association of a Cyclical Migraine Phenotype With Disease Progression: A 1-Year Time Series Analysis. Neurology. 2022. PMID: 35953289. doi:10.1212/WNL.0000000000200887
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。